Evidence map›Paper›PMID 38296945›Full record

ArticleNature communications2024

Effect of aging on the human myometrium at single-cell resolution.

Paula Punzon-Jimenez, Alba Machado-Lopez, Raul Perez-Moraga, Jaime Llera-Oyola, Daniela Grases, Marta Galvez-Viedma, Mustafa Sibai, Elena Satorres-Perez, Susana Lopez-Agullo, Rafael Badenes and 5 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
3.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 8 institutions in 2 countries.

Paula Punzon-Jimenez *Carlos Simon Foundation, Valencia, Spain.ORCID 0000-0003-1271-3852
Alba Machado-Lopez *Carlos Simon Foundation, Valencia, Spain.ORCID 0000-0003-4052-7694
Raul Perez-MoragaCarlos Simon Foundation, Valencia, Spain.ORCID 0000-0002-9611-9123
Jaime Llera-OyolaCarlos Simon Foundation, Valencia, Spain.ORCID 0000-0002-0146-6641
Daniela GrasesJosep Carreras Leukaemia Research Institute (IJC), Barcelona, Spain.
Marta Galvez-ViedmaCarlos Simon Foundation, Valencia, Spain.
Mustafa SibaiJosep Carreras Leukaemia Research Institute (IJC), Barcelona, Spain.
Elena Satorres-PerezHospital Universitario y Politécnico La Fe, Valencia, Spain.ORCID 0000-0002-3459-0737
Susana Lopez-AgulloHospital Universitario y Politécnico La Fe, Valencia, Spain.
Rafael BadenesDepartment of Surgery, University of Valencia, Valencia, Spain.ORCID 0000-0001-7017-0150
Carolina Ferrer-GomezHospital General Universitario de Valencia, Valencia, Spain.
Eduard Porta-PardoJosep Carreras Leukaemia Research Institute (IJC), Barcelona, Spain.
Beatriz RosonCarlos Simon Foundation, Valencia, Spain.ORCID 0000-0002-9851-2025
Carlos SimonCarlos Simon Foundation, Valencia, Spain. carlos.simon@uv.es.ORCID 0000-0003-0902-9531
Aymara MasCarlos Simon Foundation, Valencia, Spain. amas@fundacioncarlossimon.com.ORCID 0000-0002-5866-6732
Josep Carreras Leukaemia Research Institute · ESHospital Universitari i Politècnic La Fe · ESINCLIVA Health Research Institute · ESUniversitat de València · ESFundación General · ESHarvard University · USHospital General Universitario De Valencia · ESIgenomix · ES

Funding

EC | EU Framework Programme for Research and Innovation H2020 | H2020 European Institute of Innovation and Technology (H2020 The European Institute of Innovation and Technology) 874867Ministry of Economy and Competitiveness | Instituto de Salud Carlos III (Institute of Health Carlos III) CP19/00162Ministry of Economy and Competitiveness | Instituto de Salud Carlos III (Institute of Health Carlos III) PI20/00942Regional Government of Valencia | Conselleria d'Educació, Investigació, Cultura i Esport (Conselleria d'Educació, Investigació, Cultura i Esport de la Generalitat Valenciana) FDEGENT/2019/010
6 · The paper itself

Abstract

Age-associated myometrial dysfunction can prompt complications during pregnancy and labor, which is one of the factors contributing to the 7.8-fold increase in maternal mortality in women over 40. Using single-cell/single-nucleus RNA sequencing and spatial transcriptomics, we have constructed a cellular atlas of the aging myometrium from 186,120 cells across twenty perimenopausal and postmenopausal women. We identify 23 myometrial cell subpopulations, including contractile and venous capillary cells as well as immune-modulated fibroblasts. Myometrial aging leads to fewer contractile capillary cells, a reduced level of ion channel expression in smooth muscle cells, and impaired gene expression in endothelial, smooth muscle, fibroblast, perivascular, and immune cells. We observe altered myometrial cell-to-cell communication as an aging hallmark, which associated with the loss of 25 signaling pathways, including those related to angiogenesis, tissue repair, contractility, immunity, and nervous system regulation. These insights may contribute to a better understanding of the complications faced by older individuals during pregnancy and labor.

Indexed as

Labor, ObstetricMyometriumAgingFemaleHumansMuscle ContractionMuscle, SmoothPregnancy

Identifiers

PMID38296945
PMCPMC10830479
OpenAlexW4391383932

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.